FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2177647712> ?p ?o ?g. }

• W2177647712 endingPage "90" @default.
• W2177647712 startingPage "279" @default.
• W2177647712 abstract "Lung hyperpermeability affects the development of acute respiratory distress syndrome (ARDS), but therapeutic strategies for the control of microvascular permeability have not been established. We examined the effects of edaravone, dexamethasone, and N-monomethyl-L-arginine (L-NMMA) on permeability changes in human pulmonary microvascular endothelial cells (PMVEC) under a hypercytokinemic state. Human PMVEC were seeded in a Boyden chamber. After monolayer confluence was achieved, the culture media were replaced respectively by culture media containing edaravone, dexamethasone, and L-NMMA. After 24-h incubation, the monolayer was stimulated with tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β). Fluorescein-labeled dextran was added. Then the trans-human PMVEC leak was measured. Expressions of vascular endothelial-cadherin (VE-cadherin) and zonula occludens-1 protein (ZO-1) were evaluated using real-time quantitative polymerase chain reaction and immunofluorescence microscopy. The results showed that TNF-α＋IL-1β markedly increased pulmonary microvascular permeability. Pretreatment with edaravone, dexamethasone, or L-NMMA attenuated the hyperpermeability and inhibited the cytokine-induced reduction of VE-cadherin expression on immunofluorescence staining. Edaravone and dexamethasone increased the expression of ZO-1 at both the mRNA and protein levels. Edaravone and dexamethasone inhibited the permeability changes of human PMVEC, at least partly through an enhancement of VE-cadherin. Collectively, these results suggest a potential therapeutic approach for intervention in patients with ARDS." @default.
• W2177647712 created "2016-06-24" @default.
• W2177647712 creator A5017674529 @default.
• W2177647712 creator A5030354630 @default.
• W2177647712 creator A5037688173 @default.
• W2177647712 creator A5039677911 @default.
• W2177647712 creator A5045838890 @default.
• W2177647712 creator A5053577603 @default.
• W2177647712 creator A5057266585 @default.
• W2177647712 creator A5067372257 @default.
• W2177647712 creator A5082690216 @default.
• W2177647712 date "2015-01-01" @default.
• W2177647712 modified "2023-09-23" @default.
• W2177647712 title "Inhibitory Effects of Edaravone, a Free Radical Scavenger, on Cytokine-induced Hyperpermeability of Human Pulmonary Microvascular Endothelial Cells:A Comparison with Dexamethasone and Nitric Oxide Synthase Inhibitor." @default.
• W2177647712 cites W1976241643 @default.
• W2177647712 cites W1983057716 @default.
• W2177647712 cites W1983838150 @default.
• W2177647712 cites W1987646481 @default.
• W2177647712 cites W2028273752 @default.
• W2177647712 cites W2048276670 @default.
• W2177647712 cites W2057399508 @default.
• W2177647712 cites W2070388322 @default.
• W2177647712 cites W2070778869 @default.
• W2177647712 cites W2074745926 @default.
• W2177647712 doi "https://doi.org/10.18926/amo/53674" @default.
• W2177647712 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26490025" @default.
• W2177647712 hasPublicationYear "2015" @default.
• W2177647712 type Work @default.
• W2177647712 sameAs 2177647712 @default.
• W2177647712 citedByCount "2" @default.
• W2177647712 countsByYear W21776477122016 @default.
• W2177647712 countsByYear W21776477122021 @default.
• W2177647712 crossrefType "journal-article" @default.
• W2177647712 hasAuthorship W2177647712A5017674529 @default.
• W2177647712 hasAuthorship W2177647712A5030354630 @default.
• W2177647712 hasAuthorship W2177647712A5037688173 @default.
• W2177647712 hasAuthorship W2177647712A5039677911 @default.
• W2177647712 hasAuthorship W2177647712A5045838890 @default.
• W2177647712 hasAuthorship W2177647712A5053577603 @default.
• W2177647712 hasAuthorship W2177647712A5057266585 @default.
• W2177647712 hasAuthorship W2177647712A5067372257 @default.
• W2177647712 hasAuthorship W2177647712A5082690216 @default.
• W2177647712 hasConcept C113045295 @default.
• W2177647712 hasConcept C126322002 @default.
• W2177647712 hasConcept C134018914 @default.
• W2177647712 hasConcept C142724271 @default.
• W2177647712 hasConcept C153911025 @default.
• W2177647712 hasConcept C17991360 @default.
• W2177647712 hasConcept C185592680 @default.
• W2177647712 hasConcept C203014093 @default.
• W2177647712 hasConcept C2776151105 @default.
• W2177647712 hasConcept C2776348555 @default.
• W2177647712 hasConcept C2777622882 @default.
• W2177647712 hasConcept C2777714996 @default.
• W2177647712 hasConcept C2779554857 @default.
• W2177647712 hasConcept C2780401358 @default.
• W2177647712 hasConcept C2992339995 @default.
• W2177647712 hasConcept C519581460 @default.
• W2177647712 hasConcept C55493867 @default.
• W2177647712 hasConcept C71924100 @default.
• W2177647712 hasConcept C86803240 @default.
• W2177647712 hasConcept C98274493 @default.
• W2177647712 hasConceptScore W2177647712C113045295 @default.
• W2177647712 hasConceptScore W2177647712C126322002 @default.
• W2177647712 hasConceptScore W2177647712C134018914 @default.
• W2177647712 hasConceptScore W2177647712C142724271 @default.
• W2177647712 hasConceptScore W2177647712C153911025 @default.
• W2177647712 hasConceptScore W2177647712C17991360 @default.
• W2177647712 hasConceptScore W2177647712C185592680 @default.
• W2177647712 hasConceptScore W2177647712C203014093 @default.
• W2177647712 hasConceptScore W2177647712C2776151105 @default.
• W2177647712 hasConceptScore W2177647712C2776348555 @default.
• W2177647712 hasConceptScore W2177647712C2777622882 @default.
• W2177647712 hasConceptScore W2177647712C2777714996 @default.
• W2177647712 hasConceptScore W2177647712C2779554857 @default.
• W2177647712 hasConceptScore W2177647712C2780401358 @default.
• W2177647712 hasConceptScore W2177647712C2992339995 @default.
• W2177647712 hasConceptScore W2177647712C519581460 @default.
• W2177647712 hasConceptScore W2177647712C55493867 @default.
• W2177647712 hasConceptScore W2177647712C71924100 @default.
• W2177647712 hasConceptScore W2177647712C86803240 @default.
• W2177647712 hasConceptScore W2177647712C98274493 @default.
• W2177647712 hasIssue "5" @default.
• W2177647712 hasLocation W21776477121 @default.
• W2177647712 hasOpenAccess W2177647712 @default.
• W2177647712 hasPrimaryLocation W21776477121 @default.
• W2177647712 hasRelatedWork W1987181917 @default.
• W2177647712 hasRelatedWork W1991663943 @default.
• W2177647712 hasRelatedWork W2040818310 @default.
• W2177647712 hasRelatedWork W2060382670 @default.
• W2177647712 hasRelatedWork W2069851486 @default.
• W2177647712 hasRelatedWork W2076286594 @default.
• W2177647712 hasRelatedWork W2177647712 @default.
• W2177647712 hasRelatedWork W2383792849 @default.
• W2177647712 hasRelatedWork W2899084033 @default.
• W2177647712 hasRelatedWork W2784507924 @default.
• W2177647712 hasVolume "69" @default.
• W2177647712 isParatext "false" @default.

• next